EFFECTS OF PYRIDOXINE DEFICIENCY AND DIETARY CHOLESTEROL SUPPLEMENTATION IN THE CHICK ON PLASMA PROTEIN-BOUND IODINE, GLUTAMIC–OXALACETIC TRANSAMINASE ACTIVITY, AND 14C-ACETATE INCORPORATION INTO CHOLESTEROL

1966 ◽  
Vol 44 (5) ◽  
pp. 625-633 ◽  
Author(s):  
P. J. Lupien

The influence of B6 avitaminosis and the feeding of cholesterol on protein-bound iodine (PBI) of plasma and plasma glutamic–oxalacetic transaminase (PGOT) levels of chicks was studied, and the findings related to relative rates of 14C-acetate incorporation into plasma and liver cholesterol of chicks 3, 5, 11, and 15 days old.High plasma cholesterol levels were noted in the 11-day-old vitamin B6-deficient chicks. Liver cholesterol levels of this group were not significantly altered. Dietary cholesterol added at a level of 1% significantly increased liver and plasma cholesterol levels of the cholesterol-fed control and vitamin B6-deficient chicks; it also inhibited 14C-acetate incorporation into plasma and liver cholesterol to a much greater extent than did simple B6 avitaminosis or exogenous cholesterol per se. PBI parameters for control and vitamin B6-deficient chicks resembled those of plasma and liver cholesterol specific activity curves during the experimental period. Decreased PBI levels were noted 8 days after the beginning of the experiment in the vitamin B6-deficient birds. Dietary cholesterol significantly decreased PBI levels of 11-day-old control birds but increased it markedly 4 days later. PBI levels of the 11-day-old cholesterol-fed birds deficient in vitamin B6 were not changed, but were significantly increased 4 days later. PGOT levels were highest in 3-day-old control birds, and decreased rapidly thereafter. PGOT levels of the vitamin B6-deficient chicks were significantly decreased 3 to 4 days after the beginning of the experiment. The supplementary dietary cholesterol increased PGOT levels of 15-day-old cholesterol-fed control birds, but decreased PGOT levels of cholesterol-fed chicks deficient in vitamin B6. Although preliminary, these observations suggest an interrelationship between pyridoxine, thyroxine, and the mechanism responsible for the synthesis of cholesterol.

1964 ◽  
Vol 42 (8) ◽  
pp. 1161-1168 ◽  
Author(s):  
P. J. Lupien ◽  
B. B. Migicovsky

Physiological disturbances common to B6 avitaminosis were clearly manifested when 3-day-old chicks were fed a pyridoxine-deficient diet for 8 days. Body and liver weights were depressed but were restored to quasi-normal states after 4 days of pyridoxine supplementation (3 mg/lb diet). The elevated serum cholesterol levels observed were the result of a failure of this parameter to fall at the rate characteristic of a well-fed bird and not to a specific elevation of the serum cholesterol above the starting conditions. Liver cholesterol levels were unaffected by the hypovitaminosis. Pyridoxine supplementation rapidly re-established normal serum cholesterol levels.The significant depression of C14-acetate incorporation into liver and serum cholesterol of 7-day-old pyridoxine-deficient chicks was maintained for the next 8 days. Mevalonate-2-C14 incorporation into liver cholesterol was not significantly depressed by the hypovitaminosis at any time during the study. Unlike the controls, mevalonate-2-C14 incorporation into serum cholesterol was significantly lowered in the 11-day-old pyridoxine-deficient chicks, but not at any other time during the study.The significance of these findings and the possible relationship between these factors are discussed.


1964 ◽  
Vol 42 (4) ◽  
pp. 443-449 ◽  
Author(s):  
P. J. Lupien ◽  
B. B. Migicovsky

The effect of cholesterol feeding and of starvation on C14-acetate and mevalonate-2-C14 incorporation into serum and liver cholesterol of chicks, as well as the presence or absence of an inhibitor of cholesterol synthesis (I.C.S.) in cholesterol-fed rats, has been studied.Starvation significantly reduced C14-acetate incorporation into liver cholesterol of 15-day-old chicks, but did not affect mevalonate-2-C14 incorporation.The feeding of 1% dietary cholesterol significantly decreased both C14-acetate and mevalonate-2-C14 incorporation into liver cholesterol of the chick.Mitochondria from the livers of starved rats inhibited C14-acetate incorporation into liver cholesterol to a much greater extent than did "cholesterol-fed" or "normal" rat mitochondria.It is suggested that although starvation and cholesterol feeding both reduce the degree of acetate incorporation into cholesterol, they do so in different ways.


2020 ◽  
Vol 61 (11) ◽  
pp. 1504-1511
Author(s):  
Shaofeng Huo ◽  
Liang Sun ◽  
Geng Zong ◽  
Boyu Song ◽  
He Zheng ◽  
...  

Accompanied with nutrition transition, non-HDL-C levels of individuals in Asian countries has increased rapidly, which has caused the global epicenter of nonoptimal cholesterol to shift from Western countries to Asian countries. Thus, it is critical to underline major genetic and dietary determinants. In the current study of 2,330 Chinese individuals, genetic risk scores (GRSs) were calculated for total cholesterol (TC; GRSTC, 57 SNPs), LDL-C (GRSLDL-C, 45 SNPs), and HDL-C (GRSHDL-C, 65 SNPs) based on SNPs from the Global Lipid Genetics Consortium study. Cholesterol intake was estimated by a 74-item food-frequency questionnaire. Associations of dietary cholesterol intake with plasma TC and LDL-C strengthened across quartiles of the GRSTC (effect sizes: −0.29, 0.34, 2.45, and 6.47; Pinteraction = 0.002) and GRSLDL-C (effect sizes: −1.35, 0.17, 5.45, and 6.07; Pinteraction = 0.001), respectively. Similar interactions with non-HDL-C were observed between dietary cholesterol and GRSTC (Pinteraction = 0.001) and GRSLDL-C (Pinteraction = 0.004). The adverse effects of GRSTC on TC (effect sizes across dietary cholesterol quartiles: 0.51, 0.82, 1.21, and 1.31; Pinteraction = 0.023) and GRSLDL-C on LDL-C (effect sizes across dietary cholesterol quartiles: 0.66, 0.52, 1.12, and 1.56; Pinteraction = 0.020) were more profound in those having higher cholesterol intake compared with those with lower intake. Our findings suggest significant interactions between genetic susceptibility and dietary cholesterol intake on plasma cholesterol profiles in a Chinese population.


2013 ◽  
Vol 2 (1) ◽  
pp. 168 ◽  
Author(s):  
Brendon W. Smith ◽  
Jennifer L. King ◽  
Rita J. Miller ◽  
James P. Blue Jr. ◽  
Sandhya Sarwate ◽  
...  

<p>The cholesterol-fed rabbit is useful for atherosclerosis research. We describe development of a low-magnesium (Mg) cholesterol-containing diet to accelerate atherosclerosis in this model. Male New Zealand White rabbits were fed either chow or one of four atherogenic diets: 1% cholesterol 10% fat 0.11% Mg, 1% cholesterol 10% fat 0.40% Mg, 2% cholesterol 20% fat 0.11% Mg, or 2% cholesterol 20% fat 0.40% Mg. While feed intake decreased in cholesterol-fed rabbits, they were able to maintain their body weights. Rabbits consuming cholesterol experienced profound hypercholesterolemia and tissue lipid accumulation, with plasma cholesterol levels above 1500 mg/dl for all groups at the completion of the study. Liver and spleen lipid content and liver cholesterol content also increased. Aortic arch atheroma thickness was greatest in 1% cholesterol 10% fat 0.11% Mg animals. Tissue Mg levels decreased in cholesterol-fed animals compared to chow-fed controls, despite equal or greater serum Mg levels. Our results indicate that the 1% cholesterol 10% fat 0.11% Mg diet was optimal at promoting hypercholesterolemia and atherosclerosis while minimizing health complications for the animals. The low Mg cholesterol diet will be useful to other biomedical researchers interested in utilizing the rabbit for cardiovascular disease research.</p>


1985 ◽  
Vol 63 (5) ◽  
pp. 557-564 ◽  
Author(s):  
Sheila M. Innis

Atherosclerosis is believed to begin early in life and to develop over several decades. Elevated plasma cholesterol is a major contributing factor. Studies in animals have shown that manipulation of cholesterol metabolism during its development in pre-and early post-natal life can permanently alter cholesterol synthesis and catabolism to favour lower plasma cholesterol levels in the adult faced with a high dietary cholesterol intake. Although the mechanisms and pathways involved are likely to be different, "metabolic training" can occur as a result of both the diet fed to the mother during gestation and lactation and from the diet fed to the animal itself in early life. The presence of cholesterol itself in the suckling diet does not appear to confer any lasting improvement to cholesterol handling in either man or animals. Although much research is still required to define the time in development for effective training of specific steps in cholesterol metabolism and the primary site and mechanism of permanently altered metabolism, significant progress has been made. These studies will form the basis of this review.


2020 ◽  
Vol 22 (1) ◽  
pp. 227
Author(s):  
Giusy Rita Caponio ◽  
David Q.-H. Wang ◽  
Agostino Di Ciaula ◽  
Maria De Angelis ◽  
Piero Portincasa

Hypercholesterolemia represents one key pathophysiological factor predisposing to increasing risk of developing cardiovascular disease worldwide. Controlling plasma cholesterol levels and other metabolic risk factors is of paramount importance to prevent the overall burden of disease emerging from cardiovascular-disease-related morbidity and mortality. Dietary cholesterol undergoes micellization and absorption in the small intestine, transport via blood, and uptake in the liver. An important amount of cholesterol originates from hepatic synthesis, and is secreted by the liver into bile together with bile acids (BA) and phospholipids, with all forming micelles and vesicles. In clinical medicine, dietary recommendations play a key role together with pharmacological interventions to counteract the adverse effects of chronic hypercholesterolemia. Bioactive compounds may also be part of initial dietary plans. Specifically, soybean contains proteins and peptides with biological activity on plasma cholesterol levels and this property makes soy proteins a functional food. Here, we discuss how soy proteins modulate lipid metabolism and reduce plasma cholesterol concentrations in humans, with potential outcomes in improving metabolic- and dyslipidemia-related conditions.


2001 ◽  
Vol 34 (2) ◽  
pp. 202-209 ◽  
Author(s):  
Peter J Voshol ◽  
Nynke R Koopen ◽  
J.Marleen L de Vree ◽  
Rick Havinga ◽  
Hans M.G Princen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document